questionText: To ask the Secretary of State for Health and Social Care, what measurable improvements in (a) workforce capacity, (b) research activity, (c) clinical trial access, (d) speed of diagnosis and (e) patient outcomes are expected as a result of the work of the National Clinical Lead for Rare Cancers, the Rare Cancer Specialty Lead and the National Cancer Board; how those improvements are expected to build on previous arrangements; by what dates they are expected to be achieved; and what arrangements are in place to monitor progress and ensure accountability.